Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting

References

• Altice , F.L. , Mezger , J.A. , Hodges , J. , Bruce , R.D. , Marinovich , A. , Walton , M. , … Friedland, G.H. 2004 . Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: Implications for program replication . Clinical Infectious Diseases 38 ( Suppl. 5 ), S 376 – S387 .
   PubMed Web of Science ®Google Scholar
• Andersen , R. , Bozzette , S. , Shapiro , M. , St Clair , P. , Morton , S. , Crystal , S. , … Cunningham, W. 2000 . Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study . Health Services Research 35 ( 2 ), 389 – 416 .
   PubMed Web of Science ®Google Scholar
• Anderson , K.H. and Mitchell , J.M. 2000 . Differential access in the receipt of antiretroviral drugs for the treatment of AIDS and its implications for survival . Archives of Internal Medicine , 160 ( 20 ) : 3114 – 3120 .
   PubMed Web of Science ®Google Scholar
• Babudieri , S. , Aceti , A. , D'Offizi , G.P. , Carbonara , S. and Starnini , G. 2000 . Directly observed therapy to treat HIV infection in prisoners . Journal of the American Medical Association , 284 ( 2 ) : 179 – 180 .
   Web of Science ®Google Scholar
• Bangsberg , D.R. and Deeks , S.G. 2002 . Is average adherence to HIV antiretroviral therapy enough? . Journal of General Internal Medicine , 17 ( 10 ) : 812 – 813 .
   PubMed Web of Science ®Google Scholar
• Boyd , M.A. 2009 . Improvements in antiretroviral therapy outcomes over calendar time . Current Opinion in HIV and AIDS , 4 ( 3 ) : 194 – 199 .
   PubMed Web of Science ®Google Scholar
• Braithwaite , R.S. , Kozal , M.J. , Chang , C.C. , Roberts , M.S. , Fultz , S.L. , Goetz , M.B. , … Justice 2007 . Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies . AIDS 21 ( 12 ), 1579 – 1589 .
   PubMed Web of Science ®Google Scholar
• Bruce , R.D. , & Altice , F.L. 2007 . Clinical care of the HIV-infected drug user . Infectious Disease Clinics of North America 21 ( 1 ), 149 – 179 , ix .
   PubMed Web of Science ®Google Scholar
• Chander , G. , Himelhoch , S. and Moore , R.D. 2006 . Substance abuse and psychiatric disorders in HIV-positive patients: Epidemiology and impact on antiretroviral therapy . Drugs , 66 ( 6 ) : 769 – 789 .
   PubMed Web of Science ®Google Scholar
• Cortes , C. , Beltran , C. , Munoz , R. , Daube , E. and Wolff , M. 2008 . Impact of baseline CD4 count, immune recovery and viral suppression at 7 year of first highly active antiretroviral therapy on survival, AIDS defining events and immune recovery reactions . Revista Médica de Chile , 136 ( 12 ) : 1503 – 1510 .
   PubMed Web of Science ®Google Scholar
• Danner , S.A. , Carr , A. , Leonard , J.M. , Lehman , L.M. , Gudiol , F. , Gonzales , J. , … Pintado, V. 1995 . A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group . New England Journal of Medicine 333 ( 23 ), 1528 – 1533 .
   PubMed Web of Science ®Google Scholar
• Diabate , S. , Alary , M. and Koffi , C.K. 2007 . Determinants of adherence to highly active antiretroviral therapy among HIV-1 infected patients in Cote d/Ivoire . AIDS , 21 ( 13 ) : 1799 – 1803 .
   PubMed Web of Science ®Google Scholar
• Falster , K. , Petoumenos , K. , Chuah , J. , Mijch , A. , Mulhall , B. , Kelly , M. , & Cooper, D.A 2009 . Poor baseline immune function predicts an incomplete immune response to combination antiretroviral treatment despite sustained viral suppression . Journal of Acquired Immune Deficiency Syndromes 50 ( 3 ), 307 – 313 .
   PubMed Web of Science ®Google Scholar
• Flexner , C. 1998 . HIV-protease inhibitors . New England Journal of Medicine , 338 ( 18 ) : 1281 – 1292 .
   PubMed Web of Science ®Google Scholar
• Glass , T.R. , De Geest , S. , Weber , R. , Vernazza , P.L. , Rickenbach , M. , Furrer , H. , … Bucher, H.C 2006 . Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: The Swiss Cohort Study . Journal of Acquired Immune Deficiency Syndromes 41 ( 3 ), 385 – 392 .
   PubMed Web of Science ®Google Scholar
• Hammer , S.M. , Squires , K.E. , Hughes , M.D. , Grimes , J.M. , Demeter , L.M. , Currier , J.S. , … Fischl, M.A. 1997 . A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team . New England Journal of Medicine 337 ( 11 ), 725 – 733 .
   PubMed Web of Science ®Google Scholar
• Harocopos , A. and Hough , M. 2005 . Drug dealing in open-air markets , Washington , DC : Office of Community-Oriented Policing Services, Department of Justice .
   Google Scholar
• Hecht, F., Colfax, G., Swanson, M., & Chesney, M. (1998, February 1–5). Adherence and effectiveness of protease inhibitors in clinical practice. Paper presented at the fifth conference on retrovirus and opportunistic infections, Chicago, IL.
   Google Scholar
• Hogg, R.S., Heath, K., Bangsberg, D., Yip, B., Press, N., O'Shaughnessy, M.V., & Montaner, J.S. (2002). Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS, 16(7), 1051–1058.
   Google Scholar
• Hogg, R.S., Yip, B., Kully, C., Craib, K.J., O'Shaughnessy, M.V., Schechter, M.T., & Montaner, J.S. (1999). Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. Canadian Medical Association Journal, 160(5), 659–665.
   Google Scholar
• Karon , J.M. , Fleming , P.L. , Steketee , R.W. and De Cock , K.M. 2001 . HIV in the United States at the turn of the century: An epidemic in transition . American Journal of Public Health , 91 ( 7 ) : 1060 – 1068 .
   PubMed Web of Science ®Google Scholar
• Low-Beer , S. , Yip , B. , O'Shaughnessy , M.V. , Hogg , R.S. and Montaner , J.S. 2000 . Adherence to triple therapy and viral load response . Journal of Acquired Immune Deficiency Syndromes , 23 ( 4 ) : 360 – 361 .
   PubMed Web of Science ®Google Scholar
• Markowitz, M., Saag, M., Powderly, W.G., Hurley, A.M., Hsu, A., Valdes, J.M., … Leonard, J.M. (1995). A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. New England Journal of Medicine, 333(23), 1534–1539.
   Google Scholar
• Mathers, B.M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S.A., … Mattick, R.P. (2008). Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet, 372(9651), 1733–1745.
   Google Scholar
• Mimiaga , M.J. , Safren , S.A. , Dvoryak , S. , Reisner , S.L. , Needle , R. and Woody , G. 2010 . “We fear the police, and the police fear us”: Structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine . AIDS Care , 22 ( 11 ) : 1305 – 1313 .
   PubMed Web of Science ®Google Scholar
• Mitty , J.A. , Stone , V.E. , Sands , M. , Macalino , G. and Flanigan , T. 2002 . Directly observed therapy for the treatment of people with human immunodeficiency virus infection: A work in progress . Clinical Infectious Diseases , 34 ( 7 ) : 984 – 990 .
   PubMed Web of Science ®Google Scholar
• Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., d'Arminio Monforte, A., … Lundgren, J.D. (2003). Decline in the AIDS and death rates in the EuroSIDA study: An observational study. Lancet, 362(9377), 22–29.
   Google Scholar
• Palepu, A., Tyndall, M.W., Joy, R., Kerr, T., Wood, E., Press, N., … Montaner, J.S. (2006). Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy. Drug and Alcohol Dependence, 84(2), 188–194.
   Google Scholar
• Palepu , A. , Tyndall , M.W. , Yip , B. , O'Shaughnessy , M.V. , Hogg , R.S. and Montaner , J.S. 2003 . Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use . Journal of Acquired Immune Deficiency Syndromes , 32 ( 5 ) : 522 – 526 .
   PubMed Web of Science ®Google Scholar
• Palepu, A., Yip, B., Miller, C., Strathdee, S.A., O'Shaughnessy, M.V., Montaner, J.S., & Hogg, R.S. (2001). Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use. AIDS, 15(3), 423–424.
   Google Scholar
• Paris, D., Ledergerber, B., Weber, R., Jost, J., Flepp, M., Opravil, M., … Zimmerli, S. (1999). Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort. AIDS Research and Human Retroviruses,15(18), 1631–1638.
   Google Scholar
• Paterson, D.L., Swindells, S., Mohr, J., Brester, M., Vergis, E.N., Squier, C., … Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21–30.
   Google Scholar
• Porter , K. , Babiker , A. , Bhaskaran , K. , Darbyshire , J. , Pezzotti , P. and Walker , A.S. 2003 . Determinants of survival following HIV-1 seroconversion after the introduction of HAART . Lancet , 362 ( 9392 ) : 1267 – 1274 .
   PubMed Web of Science ®Google Scholar
• Rosenberg , P.S. 1995 . Scope of the AIDS epidemic in the United States . Science , 270 ( 5240 ) : 1372 – 1375 .
   PubMed Web of Science ®Google Scholar
• Roux, P., Carrieri, P., Villes, V., Dellamonica, P., Poizot-Martin, I., Ravaux, I., … MANIF 2000 cohort study group. (2008). The impact of methadone or buprenorphine treatment and ongoing injection in highly active antiretroviral therapy (HAART) adherence: Evidence from the MANIF 2000 cohort study. Addiction, 103(11), 1828–1836.
   Google Scholar
• Safren, S.A., Otto, M.W., Worth, J.L., Salomon, E., Johnson, W., Mayer, K., & Boswell, S. (2001). Two strategies to increase adherence to HIV antiretroviral medication: Life Steps and medication monitoring. Behaviour Research and Therapy, 39(10), 1151–1162.
   Google Scholar
• Samet, J.H., Libman, H., Steger, K.A., Dhawan, R.K., Chen, J., Shevitz, A.H., … Craven, D.E. (1992). Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: A cross-sectional study in a municipal hospital clinic. American Journal of Medicine, 92(5), 495–502.
   Google Scholar
• Shapiro, M.F., Morton, S.C., McCaffrey, D.F., Senterfitt, J.W., Fleishman, J.A., Perlman, J.F., … Bozzette, S.A. (1999). Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study. Journal of the American Medical Association, 281(24), 2305–2315.
   Google Scholar
• Sherer, R., Stieglitz, K., Narra, J., Jasek, J., Green, L., Moore, B., … Cohen, M. (2002). HIV multidisciplinary teams work: Support services improve access to and retention in HIV primary care. AIDS Care, 14(Suppl 1), S31–S44.
   Google Scholar
• Shtatland, E., Kleinman, K., & Cain, E. (2005, April 10–13). Model building in PROC PHREG with automatic variable selection and information criteria. Paper presented at the SUGI 30 proceedings, Philadelphia, PA.
   Google Scholar
• Simoni , J.M. , Amico , K.R. , Pearson , C.R. and Malow , R. 2008 . Strategies for promoting adherence to antiretroviral therapy: A review of the literature . Current Infectious Disease Reports , 10 ( 6 ) : 515 – 521 .
   PubMedGoogle Scholar
• Small , W. , Wood , E. , Betteridge , G. , Montaner , J. and Kerr , T. 2009 . The impact of incarceration upon adherence to HIV treatment among HIV positive injection drug users: A qualitative study . AIDS Care , 21 ( 6 ) : 708 – 714 .
   PubMed Web of Science ®Google Scholar
• Steiner , J.F. and Prochazka , A.V. 1997 . The assessment of refill compliance using pharmacy records: Methods, validity, and applications . Journal of Clinical Epidemiology , 50 ( 1 ) : 105 – 116 .
   PubMed Web of Science ®Google Scholar
• Stone , V.E. , Jordan , J. , Tolson , J. , Miller , R. and Pilon , T. 2004 . Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: Self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence . Journal of Acquired Immune Deficiency Syndromes , 36 ( 3 ) : 808 – 816 .
   PubMed Web of Science ®Google Scholar
• Strathdee , S.A. , Palepu , A. , Cornelisse , P.G. , Yip , B. , O'Shaughnessy , M.V. , Montaner , J.S. , … Hogg, R.S. 1998 . Barriers to use of free antiretroviral therapy in injection drug users Journal of the American Medical Association 280 ( 6 ), 547 – 549 .
   PubMed Web of Science ®Google Scholar
• Strathdee , S.A. , Patrick , D.M. , Currie , S.L. , Cornelisse , P.G. , Rekart , M.L. , Montaner , J.S. , … O'Shaughnessy, M.V. 1997 . Needle exchange is not enough: Lessons from the Vancouver injecting drug use study . AIDS 11 ( 8 ), F 59 – F65 .
   PubMed Web of Science ®Google Scholar
• Tapper , M.L. , Flexner , C. , Eron , J.J. , & Molina , J.M. 2004 . Simplifying antiretroviral therapy . AIDS Read 14 ( 7 ), 355–360 , 367 – 371 .
   Google Scholar
• Tebas , P. , Royal , M. , Fichtenbaum , C. , Blutman , J. , Arens , M. , Horgan , M. , & Powderly, W ( 1998 February 1–5 ). Relationship between adherence to HAART and disease state . Paper presented at the fifth conference on retrovirus and opportunistic infections, Chicago, IL
   Google Scholar
• Thompson , M.A. , Aberg , J.A. , Cahn , P. , Montaner , J.S. , Rizzardini , G. , Telenti , A. , … Schooley, R.T. 2010 . Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel . Journal of the American Medical Association 304 ( 3 ), 321 – 333 .
   PubMed Web of Science ®Google Scholar
• Tyndall , M.W. , Currie , S. , Spittal , P. , Li , K. , Wood , E. , O'Shaughnessy , M.V. , & Schechter, M.T 2003 . Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic . AIDS 17 ( 6 ), 887 – 893 .
   PubMed Web of Science ®Google Scholar
• Uhlmann , S. , Milloy , M.J. , Kerr , T. , Zhang , R. , Guillemi , S. , Marsh , D. , & Schechtern, M.T 2010 . Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users . Addiction 105 ( 5 ), 907 – 913 .
   PubMed Web of Science ®Google Scholar
• UNAIDS . 2009 . Epidemic Update 2009. Joint Programme on HIV/AIDS . Geneva, Switzerland: UNAIDS.
   Google Scholar
• Vanhove , G.F. , Schapiro , J.M. , Winters , M.A. , Merigan , T.C. and Blaschke , T.F. 1996 . Patient compliance and drug failure in protease inhibitor monotherapy . Journal of the American Medical Association , 276 ( 24 ) : 1955 – 1956 .
   PubMed Web of Science ®Google Scholar
• Vlahov , D. and Celentano , D.D. 2006 . Access to highly active antiretroviral therapy for injection drug users: Adherence, resistance, and death . Cadernos de Saúde Pública , 22 ( 4 ) : 705 – 718 .
   PubMedGoogle Scholar
• Weber , R. , Huber , M. , Rickenbach , M. , Furrer , H. , Eliza , L. , Hirschel , B. , … Swiss HIV Cohort Study 2009 . Uptake of and virological response to antiretroviral therapy among HIV infected former and current injecting drug users and persons in an opiate substitution treatment programme: The Swiss HIV cohort study . HIV Medicine 10 ( 7 ), 407 – 416 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Hogg , R.S. , Bonner , S. , Kerr , T. , Li , K. , Palepu , A. , … Montaner, J.S. 2004 . Staging for antiretroviral therapy among HIV-infected drug users . Journal of the American Medical Association 292 ( 10 ), 1175 – 1177 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Hogg , R.S. , Lima , V.D. , Kerr , T. , Yip , B. , Marshall , B.D. , & Montaner, J.S. 2008 . Highly active antiretroviral therapy and survival in HIV-infected injection drug users . Journal of the American Medical Association 300 ( 5 ), 550 – 554 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Hogg , R.S. , Yip , B. , Harrigan , P.R. , O'Shaughnessy , M.V. and Montaner , J.S. 2003 . Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350×10(9) cells/L . Annals of Internal Medicine , 139 ( 10 ) : 810 – 816 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Montaner , J.S. , Tyndall , M.W. , Schechter , M.T. , O'Shaughnessy , M.V. and Hogg , R.S. 2003 . Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy . Journal of Infectious Diseases , 188 ( 8 ) : 1164 – 1170 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Montaner , J.S. , Yip , B. , Tyndall , M.W. , Schechter , M.T. , O'Shaughnessy , M.V. , & Hogg, R.S. 2003 . Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users . Canadian Medical Association Journal 169 ( 7 ), 656 – 661 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Spittal , P.M. , Small , W. , Kerr , T. , Li , K. , Hogg , R.S. , … Schechter, M.T. 2004 . Displacement of Canada's largest public illicit drug market in response to a police crackdown . Canadian Medical Association Journal 170 ( 10 ), 1551 – 1556 .
   PubMed Web of Science ®Google Scholar